Collegium Pharmaceutical (COLL) Stock Chart & Stock Price History → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free COLL Stock Alerts $32.27 -0.87 (-2.63%) (As of 06/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Collegium Pharmaceutical Stock Price Performance5 Day Performance-2.80%1 Month Performance-13.97%3 Month Performance-13.09%6 Month Performance+26.05%Year-To-Date Performance+4.84%1 Year Performance+49.19% Receive COLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsThe Hidden Anchor Investment of the Elite RevealedThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. COLL Stock Chart for Monday, June, 3, 2024 COLL Chart by TradingView Collegium Pharmaceutical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/03/2024$33.14$32.27-2.63%$33.41$32.17516,142 shs$1.06 billion05/31/2024$32.43$33.14+2.19%$33.50$32.28566,503 shs$1.08 billion05/30/2024$33.20$32.43-2.32%$33.65$32.08877,216 shs$1.06 billion05/29/2024$34.37$33.20-3.40%$34.18$32.80417,544 shs$1.09 billion05/28/2024$34.25$34.37+0.35%$34.47$33.87352,406 shs$1.12 billion05/27/2024$34.25$34.25$34.55$33.68320,900 shs$1.12 billion Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 05/24/2024$33.82$34.25+1.27%$34.55$33.68319,063 shs$1.12 billion05/23/2024$34.18$33.82-1.05%$34.55$33.34297,651 shs$1.11 billion05/22/2024$34.50$34.18-0.93%$34.82$34.03274,088 shs$1.12 billion05/21/2024$34.15$34.50+1.02%$34.86$34.14343,823 shs$1.13 billion05/20/2024$32.47$34.15+5.17%$34.22$32.40404,721 shs$1.12 billion05/17/2024$33.67$32.47-3.56%$33.74$32.38385,065 shs$1.06 billion05/16/2024$33.98$33.67-0.91%$34.11$33.32378,763 shs$1.10 billion05/15/2024$33.29$33.98+2.07%$34.81$33.301.17 million shs$1.11 billion05/14/2024$32.15$33.29+3.55%$33.33$31.79732,658 shs$1.09 billion05/13/2024$31.50$32.15+2.06%$33.35$31.37884,500 shs$1.05 billion05/10/2024$37.86$31.50-16.80%$34.00$30.472.25 million shs$1.03 billion05/09/2024$38.06$37.86-0.53%$38.60$37.60363,953 shs$1.24 billion05/08/2024$37.30$38.06+2.04%$38.28$37.22316,992 shs$1.24 billion05/07/2024$37.02$37.30+0.76%$37.65$37.00199,326 shs$1.22 billion05/06/2024$37.51$37.02-1.31%$37.92$36.88304,924 shs$1.21 billion05/03/2024$37.51$37.51$38.32$37.29297,795 shs$1.23 billion05/02/2024$37.78$37.51-0.71%$38.16$37.18312,815 shs$1.23 billion05/01/2024$36.93$37.78+2.30%$38.46$37.03369,821 shs$1.24 billion04/30/2024$36.71$36.93+0.60%$38.18$36.75330,948 shs$1.21 billion04/29/2024$36.42$36.71+0.80%$37.17$36.51212,112 shs$1.20 billion04/26/2024$35.84$36.42+1.62%$36.57$35.79252,821 shs$1.19 billion04/25/2024$35.48$35.84+1.01%$36.01$35.05338,007 shs$1.17 billion04/24/2024$35.94$35.48-1.28%$36.02$35.33302,816 shs$1.16 billion04/23/2024$34.74$35.94+3.45%$36.51$34.92618,658 shs$1.18 billion04/22/2024$34.84$34.74-0.29%$35.30$34.55414,728 shs$1.14 billion04/19/2024$34.77$34.84+0.20%$35.34$34.24325,319 shs$1.14 billion04/18/2024$35.45$34.77-1.92%$35.47$34.69203,938 shs$1.14 billion04/17/2024$35.40$35.45+0.14%$35.73$34.83256,530 shs$1.16 billion04/16/2024$35.14$35.40+0.74%$35.81$34.75323,773 shs$1.16 billion04/15/2024$35.71$35.14-1.60%$35.83$35.12366,302 shs$1.15 billion04/12/2024$36.39$35.71-1.87%$36.51$35.47380,381 shs$1.17 billion04/11/2024$37.99$36.39-4.21%$37.97$35.72462,878 shs$1.19 billion04/10/2024$38.79$37.99-2.06%$38.89$37.95311,406 shs$1.24 billion04/09/2024$39.42$38.79-1.60%$39.53$38.41204,177 shs$1.24 billionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/08/2024$39.99$39.42-1.43%$40.02$38.89235,209 shs$1.26 billion04/05/2024$39.30$39.99+1.76%$40.24$39.05384,715 shs$1.28 billion04/04/2024$39.45$39.30-0.38%$40.49$39.17366,245 shs$1.26 billion04/03/2024$38.40$39.45+2.73%$39.46$38.24261,625 shs$1.26 billion04/02/2024$38.88$38.40-1.23%$39.03$38.12335,174 shs$1.23 billion04/01/2024$38.82$38.88+0.15%$38.97$37.63351,382 shs$1.24 billion03/29/2024$38.82$38.82$40.95$38.59613,299 shs$1.24 billion03/28/2024$40.91$38.82-5.11%$40.95$38.59613,299 shs$1.24 billion03/27/2024$39.93$40.91+2.45%$40.91$39.97362,313 shs$1.31 billion03/26/2024$40.16$39.93-0.57%$40.32$39.44335,554 shs$1.28 billion03/25/2024$39.72$40.16+1.11%$40.59$39.55273,351 shs$1.28 billion03/22/2024$39.66$39.72+0.15%$39.96$39.13319,417 shs$1.27 billion03/21/2024$38.79$39.66+2.24%$39.80$38.47584,073 shs$1.27 billion03/20/2024$37.96$38.79+2.19%$38.88$37.29519,232 shs$1.24 billion03/19/2024$39.35$37.96-3.53%$39.37$37.74855,053 shs$1.21 billion03/18/2024$39.09$39.35+0.67%$39.90$38.86502,272 shs$1.26 billion03/15/2024$38.03$39.09+2.79%$39.45$37.641.99 million shs$1.25 billion03/14/2024$38.30$38.03-0.70%$38.33$37.21383,451 shs$1.22 billion03/13/2024$37.40$38.30+2.41%$38.48$37.01337,755 shs$1.22 billion03/12/2024$37.50$37.40-0.27%$37.72$36.79310,737 shs$1.20 billion03/11/2024$37.60$37.50-0.27%$37.97$36.97495,658 shs$1.20 billion03/08/2024$37.20$37.60+1.08%$38.39$37.34427,986 shs$1.20 billion03/07/2024$36.68$37.20+1.42%$37.23$36.46332,330 shs$1.19 billion03/06/2024$36.31$36.68+1.02%$36.92$35.91403,353 shs$1.17 billion03/05/2024$37.03$36.31-1.94%$37.09$35.92318,168 shs$1.16 billion03/04/2024$37.13$37.03-0.27%$37.65$36.61294,944 shs$1.18 billion Related Companies: NKTR Stock Chart INZY Stock Chart EGRX Stock Chart ALPN Stock Chart NUVL Stock Chart ALKS Stock Chart PRGO Stock Chart CRNX Stock Chart AXSM Stock Chart BHVN Stock Chart Receive COLL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COLL) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThe Only Energy Play You Should Be Looking AtWealthpin ProElon Musk’s Final Masterpiece: “X-9840”Paradigm PressCollapse of the Petrodollar Colonial Metals[Webinar] Understanding Covered CallsOICWas the Great Financial Crisis fun?Brooks EnterprisesWhat’s Pelosi Buying Now?Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.